Quick Answer
Microbot Medical Inc. reported Cash and Equivalents of $3.91 million for fiscal year 2025.
Microbot Medical Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $3.91M | +25.6% |
| 2024 | $3.11M | +26.2% |
| 2023 | $2.47M | +1.1% |
| 2022 | $2.44M | -81.9% |
| 2021 | $13.49M | -31.3% |
| 2020 | $19.65M | -31.7% |
| 2019 | $28.77M | +449.3% |
| 2018 | $5.24M | -51.4% |
| 2017 | $10.79M | +298.2% |
| 2016 | $2.71M | +519.9% |
| 2015 | $437.0K | -44.8% |
| 2014 | $791.0K | -97.4% |
| 2013 | $30.59M | +261.0% |
| 2012 | $8.47M | -36.4% |
| 2011 | $13.31M | -32.5% |
| 2010 | $19.71M | -49.0% |
| 2009 | $38.62M | +28.5% |
| 2008 | $30.04M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.70M | +1299.6% | +64.2% |
| June 30, 2025 | $4.08M | +65.6% | +26.9% |
| March 31, 2025 | $3.22M | +176.9% | +3.3% |
| December 31, 2024 | $3.11M | +26.2% | +550.1% |
| September 30, 2024 | $479.0K | -64.1% | -80.6% |
| June 30, 2024 | $2.46M | -56.9% | +112.1% |
| March 31, 2024 | $1.16M | -46.0% | -52.9% |
| December 31, 2023 | $2.47M | +1.1% | +84.9% |
- Microbot Medical Inc. showed an increase of +25.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, Microbot Medical Inc.’s cash and equivalents has declined by 87.0% (from $30.04 million to $3.91 million).
- The most recent figure is from Microbot Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: